most read article

Asahi Kasei to Exit MMA and PMMA Businesses

Asahi Kasei will end the production of methyl methacrylate (MMA) monomer and other chemicals and focus on its Energy & Infrastructure division.

News • Pharma

Evonik Invests €93 Million in Vancouver GMP Plant to Triple LNP Capacity

New GMP (Good Manufacturing Practice) facility to meet increasing demand for lipid nanoparticle (LNP) development and clinical drug product manufacturing.

News • Pharma

Cambrex Advances US and European Expansions

Cambrex is advancing its $150 million investment to expand API manufacturing in Iowa and enhance R&D and manufacturing capabilities in Milan, strengthening its services in the US and Europe.

News

Novo Nordisk Restructures R&D Services in the US

Danish pharma Novo Nordisk is expanding its R&D capabilities in Boston, Massachusetts, US, which will lead to the closure of a facility in Indianapolis and a restructuring of its Seattle operations.

News

Evonik Appoints Claus Rettig as Interim CEO

Until further notice, Rettig is taking over the duties of Christian Kullmann, who is recovering in the coming weeks from a recent serious, unplanned surgery.

News

BASF schließt Verkauf von Solenis an Platinum Equity ab

Nach Genehmigung durch alle zuständigen Behörden haben BASF und Clayton, Dubilier & Rice die Veräußerung von Solenis an Platinum Equity abgeschlossen. Die Transaktion impliziert einen Unternehmenswert für Solenis von 5,25 Mrd. USD, dieser Betrag beinhaltet Nettofinanzschulden von rund 2,5 Mrd. USD.